Toujeo for the Treatment of Type 1 and Type 2 Diabetes
Toujeo (insulin glargine [rDNA origin]) is an insulin injection approved for the treatment of type 1 and type 2 diabetes to improve glycaemic control in adult patients.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Forteo | Insulin | Lantus | Pharmaceuticals